Ischemic heart disease (myocardial perfusion and viability): Techniques and results;Cardiopathies ischémiques (perfusion myocardique et viabilité): Techniques et résultats

Journal de Radiologie

Volumn 85, Issue 10 II, 2004, Pages 1811-1818

  Croisille, P ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

MR, perfusion study; Myocardium, ischemia; Myocardium, MR

Indexed keywords

GADOLINIUM;

CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC IMAGING; DISEASE SEVERITY; HEART MUSCLE PERFUSION; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; ISCHEMIC HEART DISEASE; KINETICS; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; RR INTERVAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 7744222647     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0221-0363(04)97752-9     Document Type: Review

References (40)

1. Doyle JT, Kannel WB, McNamara PM, Quickenton P, Gordon T. Factors related to suddenness of death from coronary disease: combined Albany-Framingham studies. Am J Cardiol 1976;37: 1073-8.
2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992;326:242-50.
3. Gould KL, Westcott RJ, Albro PC, Hamilton GW. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. II. Clinical methodology and feasibility. Am J Cardiol 1978;41:279-87.
4. Nitenberg A, Foult JM. Réserve coronaire: évaluation dynamique de la circulation coronaire. Arch Mal Coeur Vaiss 1987;80:33-42.
5. Kroll K, Wilke N, Jerosch-Herold M et al. Modeling regional myocardial flows from residue functions of an intravascular indicator. Am J Physiol 1996;271:H1643-55.
6. Schwitter J, Saeed M, Wendland MF et al. Assessment of myocardial function and perfusion in a canine model of non-occlusive coronary artery stenosis using fast magnetic resonance imaging. J Magn Reson Imaging 1999;9:101-10.
7. Brasch RC. New directions in the development of MR imaging contrast media. Radiology 1992;183:1-11.
8. Saeed M, Wendland MF, Higgins CB. The developing role of magnetic resonance contrast media in the detection of ischemic heart disease. Proc Soc Exp Biol Med 1995;208:238-54.
9. Al-Saadi N, Nagel E, Gross M et al. Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation 2000;101:1379-83.
10. Schwitter J, Debatin JF, von Schulthess GK, McKinnon GC. Normal myocardial perfusion assessed with multishot echo-planar imaging. Magn Reson Med 1997;37:140-7.
11. Epstein FH, London JF, Peters DC et al. Multislice first-pass cardiac perfusion MRI: validation in a model of myocardial infarction. Magn Reson Med 2002;47:482-91.
12. Jerosch M, Wilke N. MR first pass imaging: quantitative assessment of transmural perfusion and collateral flow. Int J Cardiac Imag 1997;13:205-18.
13. Wilke N, Jerosch-Herold M, Wang Y et al. Myocardial perfusion reserve: assessment with multisection, quantitative, first-pass MR imaging. Radiology 1997;204:373-84.
14. Schreiber WG, Schmitt M, Kalden P et al. Dynamic contrast-enhanced myocardial perfusion imaging using saturation-prepared TrueFISP. J Magn Reson Imaging 2002;16:641-52.
15. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002;47:372-83.
16. Croisille P, Viallon M, Jacquier A et al. Comparison of new late enhancement MR imaging techniques for myocardial infarction lesion assessment at 1.5 T. In: ISMRM Proceedings, Kyoto, 2004.
17. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
18. Manning WJ, Atkinson DJ, Grossman W, Paulin S, Edelman RR. First-pass nuclear magnetic resonance imaging studies using gadolinium-DTPA in patients with coronary artery disease. J Am Coll Cardiol 1991;18:959-65.
19. Wilke NM, Jerosch-Herold M, Zenovich A, Stillman AE. Magnetic resonance first-pass myocardial perfusion imaging: clinical validation and future applications. J Magn Reson Imaging 1999;10:676-85.
20. Wilke N, Jerosch-Herold M. Assessing myocardial perfusion in coronary artery disease with magnetic resonance first-pass imaging. Cardiol Clin 1998;16:227-46.
21. Van Rugge FP, van dWE, Bruschke AV. New developments in pharmacologic stress imaging. Am Heart J 1992;124:468-85.
22. Nagel E, Underwood R, Pennell D et al. New developments in non-invasive cardiac imaging: critical assessment of the clinical role of cardiac magnetic resonance imaging. Eur Heart J 1998;19:1286-93.
23. Cullen JH, Horsfield MA, Reek CR et al. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 1999;33:1386-94.
24. Boudraa AO, Behloul F, Janier M et al. Temporal covariance analysis of first-pass contrast-enhanced myocardial magnetic resonance images. Comput Biol Med 2001;31:133-42.
25. Gurchumelidze S, Rodenwaldt J, Jerosch-Herold M et al. Do we need quantitative MR perfusion imaging? Graded myocardial perfusion changes assessed with MR and intravascular contrast agent. In: Society for Cardiovascular Magnetic Resonance. Altanta, GA, 1998,140.
26. Kraitchman DL, Wilke N, Hexeberg E et al. Myocardial perfusion and function in dogs with moderate coronary stenosis. Magn Reson Med 1996;35:771-80.
27. Mazzadi AN, Janier M, Lionnet M et al. Factor Analysis of Medical Image Sequences (FAMIS) improves Evaluation of First-Pass MRI Acquisitions for Myocardial Perfusion. Acad Radiol 2002;9:26-39.
28. Kraitchman DL, Young AA, Bloomgarden DC, et al. Integrated MRI assessment of regional function and perfusion in canine myocardial infarction. Magn Reson Med 1998;40:311-26.
29. Rogers WJ, Jr., Kramer CM, Geskin G, et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation 1999;99:744-50.
30. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 1989;80:1846-61.
31. Judd RM, Lugo-Olivieri CH, Arai M et al. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92:1902-10.
32. Lima JA, Judd RM, Bazille A et al. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 1995;92:1117-25.
33. Fedele F, Scopinaro F, Montesano T et al. Characterization of reversible myocardial dysfunction by magnetic resonance imaging. Herz 1994;19:210-20.
34. Pereira RS, Prato FS, Wisenberg G, Sykes J. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med 1996;36: 684-93.
35. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002;105: 224-9.
36. Fieno DS, Kim RJ, Chen EL et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36:1985-91.
37. Choi KM, Kim RJ, Gubernikoff G et al. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-7.
38. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation 2000;102:1678-83.
39. Klein C, Nekolla SG, Bengel FM et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002; 105:162-7.
40. Wagner A, Mahrholdt H, Holly TA et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374-9.